Kindstar Globalgene Technology, Inc. (HKG:9960)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.160
+0.010 (0.87%)
Apr 29, 2026, 3:45 PM HKT
-14.07%
Market Cap 1.15B
Revenue (ttm) 1.04B
Net Income (ttm) -65.37M
Shares Out 997.12M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend 0.10 (8.26%)
Ex-Dividend Date Jun 9, 2026
Volume 276,500
Average Volume 503,558
Open 1.170
Previous Close 1.150
Day's Range 1.140 - 1.170
52-Week Range 1.030 - 1.750
Beta 0.63
RSI 49.73
Earnings Date Aug 28, 2026

About HKG:9960

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, m... [Read more]

Sector Healthcare
Founded 2003
Employees 3,100
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9960
Full Company Profile

Financial Performance

In 2025, HKG:9960's revenue was 933.57 million, an increase of 0.65% compared to the previous year's 927.57 million. Losses were -58.74 million, 7.61% more than in 2024.

Financial numbers in CNY Financial Statements

News

There is no news available yet.